Liang Juan, Yagasaki Hiroshi, Kamachi Yoshiro, Hama Asahito, Matsumoto Kimikazu, Kato Kouji, Kudo Kazuko, Kojima Seiji
Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Haematologica. 2006 May;91(5):656-8. Epub 2006 Apr 19.
Recent studies indicate that a subset of patients with apparently acquired aplastic anemia (AA) have mutations in genes for telomerase ribonucleoprotein complex components. We looked for mutations in telomerase RNA (TERC) and telomerase reverse transcriptase (TERT) in 96 Japanese children with acquired AA and in 76 healthy controls. No mutations in TERC were found in any subjects. Novel heterozygous, non-synonymous mutations in TERT (T726M and G682D) were found in two patients with AA, neither of whom had clinical characteristics suggesting constitutional AA. This genetic difference does not explain the higher incidence of AA in Asian populations.
近期研究表明,一部分看似获得性再生障碍性贫血(AA)患者的端粒酶核糖核蛋白复合体成分基因存在突变。我们在96名患获得性AA的日本儿童及76名健康对照者中寻找端粒酶RNA(TERC)和端粒酶逆转录酶(TERT)的突变。所有受试者均未发现TERC突变。在两名AA患者中发现了TERT的新型杂合非同义突变(T726M和G682D),这两名患者均没有提示先天性AA的临床特征。这种基因差异并不能解释亚洲人群中AA的较高发病率。